933035-05-3Relevant academic research and scientific papers
CD73 INHIBITING 2,4-DIOXOPYRIMIDINE COMPOUNDS
-
Paragraph 1734, (2021/11/06)
The present disclosure provides pyrimidine dione compounds, and pharmaceutical compositions thereof, for treating cancer, including solid tumors. The compounds can be used alone or in combination with other anti-cancer agents.
Fused heterocyclic compounds useful as kinase modulators
-
Page/Page column 53, (2010/11/26)
Compounds having the formula (1), and enantiomers, and diastereomers, pharmaceutically-acceptable salts, thereof, are usefuil as kinase modulators, including MK2 modulation, wherein one of E and F is a nitrogen atom and the other of E and F is a carbon atom, Z is N or CR3, and R1, R2, R3, X and Y are as defined herein.
